A 58-year-old man presents to the emergency department with a 2-day history of nausea, vom… — USMLE Step 3

A $58$ -year-old man presents to the emergency department with a $2$ -day history of nausea, vomiting, abdominal pain, and poor oral intake. He has a history of type 2 diabetes mellitus, hypertension, and hyperlipidemia. His medications include metformin, dapagliflozin, lisinopril, and atorvastatin.

Temperature is $37.1^\circ$ C ( $98.8^\circ$ F), blood pressure is $102/64$ mmHg, pulse is $112$ /min, and respirations are $24$ /min. Physical examination shows dry mucous membranes and diffuse mild abdominal tenderness without rebound or guarding.

Laboratory studies show:
Na $^+$ : $132$ mEq/L
K $^+$ : $4.8$ mEq/L
Cl $^-$ : $98$ mEq/L
HCO $_3^-$ : $14$ mEq/L
Urea nitrogen (BUN): $38$ mg/dL
Creatinine: $1.6$ mg/dL
Glucose: $185$ mg/dL
Ketones: Positive

Arterial blood gas on room air:
pH: $7.24$
pCO $_2$ : $28$ mmHg
pO $_2$ : $95$ mmHg

Which of the following intravenous regimens is the most appropriate pharmacologic management for this patient?

A
$5\%$ dextrose and normal saline
B
Continuous regular insulin and normal saline
Continuous regular insulin, $5\%$ dextrose, and normal salineCevap
D
Sodium bicarbonate and normal saline
E
Subcutaneous insulin aspart and normal saline

Cevap

Continuous regular insulin,

5\%

dextrose, and normal saline

The patient presents with a high anion gap metabolic acidosis, ketonemia, and a relatively normal blood glucose level (

185

mg/dL) in the setting of recent poor oral intake and use of an SGLT2 inhibitor (dapagliflozin). This is classic for euglycemic diabetic ketoacidosis (DKA). SGLT2 inhibitors cause significant urinary glucose loss, lowering serum glucose and subsequently decreasing endogenous insulin secretion while increasing glucagon secretion. This hormonal shift stimulates lipolysis and ketogenesis, leading to DKA without marked hyperglycemia. The cornerstone of DKA management is fluid resuscitation and continuous intravenous regular insulin to halt ketogenesis. However, because the patient's blood glucose is already below the typical

200

250

mg/dL threshold, initiating insulin without concurrent dextrose will precipitate severe hypoglycemia. Therefore, the most appropriate pharmacologic regimen must simultaneously include continuous intravenous regular insulin, normal saline for volume expansion, and

5\%

dextrose to maintain euglycemia while the insulin clears the ketones.

Adım Adım Çözüm

Calculate the anion gap and identify the primary acid-base disorder.

Anion gap =

132 - (98 + 14) = 20

mEq/L. Combined with pH

7.24

, this indicates a high anion gap metabolic acidosis.

Determining the acid-base disorder is the first step in diagnosing the cause of the patient's presentation.

Correlate the metabolic acidosis with the clinical history and medication list.

The presence of positive ketones, use of dapagliflozin, and blood glucose

< 250

mg/dL establishes the diagnosis of euglycemic diabetic ketoacidosis (DKA).

SGLT2 inhibitors are a known trigger for euglycemic DKA, particularly during periods of decreased oral intake or acute illness.

Select the appropriate fluid and insulin regimen based on the patient's blood glucose level.

Because the blood glucose is

185

mg/dL (below the typical

200

250

mg/dL threshold), the regimen must include dextrose alongside continuous IV insulin and normal saline.

Insulin is required to suppress ketogenesis, but dextrose is necessary to prevent insulin-induced hypoglycemia.

Anahtar Kavram

Euglycemic Diabetic Ketoacidosis (DKA) Management

Tahmini Süre:2m 0s

Soru

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Konular

Bu konudan daha fazla soru